BorgWarner
BWA
62.36
-1.00
-1.58%
BorgWarner
US · BWA
#1303 by market cap
Listed 1970
62.36
-1.00
-1.58%
Live - 5344 symbols - heartbeat 210s ago
· 2026-10-08 07:37
Pre-market
62.36
0.00%
After-hours
62.36
0.00%
- Market cap
- 12.70B
- P/E (TTM)i
- 30.72
- P/Bi
- 2.26
- EPSi
- 1.28
- Div yieldi
- 1.09%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on BWA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.27, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.63% YoY
Margins
- Gross margin
- 18.68%
- Operating margin
- 9.24%
- Net margin
- 1.93%
Key ratios & quality
- Enterprise valuei
- 14.32B
- Altman Z-Scorei
- 3.27
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.53B | 10.17B | 10.17B | 11.80B | 12.64B | 14.20B | 14.09B | 14.32B |
| Gross profit | 2.23B | 2.10B | 1.91B | 2.17B | 2.37B | 2.57B | 2.65B | 2.67B |
| Selling & admin expenses | 946.00M | 873.00M | 951.00M | 1.09B | 1.29B | 1.32B | 1.35B | 1.32B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.29B | 1.23B | 925.00M | 1.10B | 1.08B | 1.26B | 1.30B | 1.32B |
| Pretax profit | 1.20B | 1.27B | 964.00M | 510.00M | 913.00M | 991.00M | 539.00M | 524.00M |
| Tax | 211.00M | 468.00M | 397.00M | 65.00M | 195.00M | 289.00M | 111.00M | 189.00M |
| Net profit | 985.00M | 797.00M | 567.00M | 639.00M | 1.03B | 695.00M | 399.00M | 335.00M |
| Basic EPS | 4 | 4 | 2 | 2 | 4 | 3 | 2 | 1 |
| Diluted EPS | 4.44 | 3.61 | 2.34 | 2.24 | 3.99 | 2.67 | 1.50 | 1.28 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.52B | 3.64B | 3.59B | 3.57B | 3.53B | 3.65B |
| Gross profit | 639.00M | 640.00M | 664.00M | 731.00M | 677.00M | 721.00M |
| Selling & admin expenses | 315.00M | 323.00M | 341.00M | 342.00M | 328.00M | 331.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 326.00M | 320.00M | 323.00M | 353.00M | 354.00M | 390.00M |
| Pretax profit | 232.00M | 284.00M | 248.00M | -240.00M | 328.00M | 372.00M |
| Tax | 61.00M | 52.00M | 75.00M | 1.00M | 73.00M | 81.00M |
| Net profit | 171.00M | 232.00M | 173.00M | -241.00M | 255.00M | 291.00M |
| Basic EPS | 1 | 1 | 1 | -1 | 1 | 1 |
| Diluted EPS | 0.72 | 1.03 | 0.73 | -1.27 | 1.16 | 1.34 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.81B | 3.84B | 6.17B | 6.60B | 6.62B | 6.22B | 6.52B | 6.80B |
| Cash & ST investments | 739.00M | 832.00M | 1.65B | 1.84B | 1.08B | 1.53B | 2.09B | 2.31B |
| Inventory | 781.00M | 807.00M | 1.29B | 1.53B | 1.22B | 1.31B | 1.25B | 1.21B |
| Total assets | 10.10B | 9.70B | 16.03B | 16.58B | 16.99B | 14.45B | 13.99B | 13.77B |
| Total current liabilities | 2.40B | 2.33B | 3.81B | 3.80B | 4.24B | 3.77B | 3.65B | 3.28B |
| Short-term debt | 173.00M | 304.00M | 96.00M | 109.00M | 82.00M | 110.00M | 436.00M | 41.00M |
| Long-term debt | 1.94B | 1.67B | 3.74B | 4.26B | 4.14B | 3.71B | 3.76B | 3.89B |
| Total liabilities | 5,750,000,000.00 | 4,858,000,000.00 | 9,305,000,000.00 | 9,313,000,000.00 | 9,486,000,000.00 | 8,387,000,000.00 | 8,287,000,000.00 | 8,155,000,000.00 |
| Total equity | 4.35B | 4.84B | 6.72B | 7.26B | 7.51B | 6.07B | 5.71B | 5.61B |
| Retained earnings | 5.34B | 5.94B | 6.30B | 6.67B | 7.45B | 6.15B | 6.41B | 6.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.38B | 6.78B | 6.98B | 6.80B | 6.74B | 7.09B |
| Cash & ST investments | 1.71B | 2.04B | 2.17B | 2.31B | 2.11B | 2.45B |
| Inventory | 1.21B | 1.22B | 1.23B | 1.21B | 1.20B | 1.23B |
| Total assets | 13.83B | 14.40B | 14.50B | 13.77B | 13.65B | 13.93B |
| Total current liabilities | 3.23B | 3.35B | 3.40B | 3.28B | 3.17B | 3.33B |
| Short-term debt | 98.00M | 44.00M | 42.00M | 41.00M | 42.00M | 40.00M |
| Long-term debt | 3.80B | 3.90B | 3.89B | 3.89B | 3.88B | 3.86B |
| Total liabilities | 7,940,000,000.00 | 8,330,000,000.00 | 8,346,000,000.00 | 8,155,000,000.00 | 8,011,000,000.00 | 8,136,000,000.00 |
| Total equity | 5.89B | 6.07B | 6.15B | 5.61B | 5.64B | 5.80B |
| Retained earnings | 6.55B | 6.75B | 6.87B | 6.57B | 6.78B | 7.02B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.13B | 1.01B | 1.18B | 1.21B | 1.18B | 1.40B | 1.38B | 1.65B |
| Depreciation & amortization | 431.00M | 439.00M | 568.00M | 574.00M | 552.00M | 582.00M | 673.00M | 719.00M |
| Free cash flow | 580.00M | 527.00M | 723.00M | 694.00M | 558.00M | 565.00M | 729.00M | 1.21B |
| Dividends paid | -142.00M | -140.00M | -146.00M | -162.00M | -161.00M | -130.00M | -98.00M | -119.00M |
| Stock buybacks / issuance | -150.00M | -100.00M | -216.00M | 0 | -240.00M | -177.00M | -402.00M | -508.00M |
| Ending cash balance | 739.00M | 832.00M | 1.65B | 1.84B | 1.34B | 1.53B | 2.09B | 2.31B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 82.00M | 579.00M | 368.00M | 619.00M | 152.00M | 586.00M |
| Depreciation & amortization | 155.00M | 179.00M | 219.00M | 166.00M | 145.00M | 149.00M |
| Free cash flow | -37.00M | 502.00M | 257.00M | 486.00M | 9.00M | 490.00M |
| Dividends paid | -24.00M | -24.00M | -36.00M | -35.00M | -35.00M | -34.00M |
| Stock buybacks / issuance | 0 | -108.00M | -102.00M | -298.00M | -150.00M | -100.00M |
| Ending cash balance | 1.71B | 2.04B | 2.17B | 2.31B | 2.11B | 2.45B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.44 | 16.70 | 8.98 | 8.03 | 13.32 | 9.58 | 5.95 | 5.05 |
| ROA %i | 9.36 | 7.54 | 3.89 | 3.29 | 5.62 | 3.97 | 2.38 | 2.00 |
| ROIC %i | 15.91 | 11.81 | 6.34 | 5.59 | 8.51 | 6.09 | 3.68 | 3.12 |
| 5-year avg ROE %i | 17.62 | 17.30 | 15.88 | 13.97 | 14.10 | 11.32 | 9.17 | 8.39 |
| EBIT margin %i | 11.92 | 12.98 | 10.20 | 6.03 | 8.83 | 7.49 | 4.42 | 4.35 |
| FCF / sales %i | 5.51 | 5.18 | 7.11 | 4.30 | 5.35 | 3.98 | 5.18 | 8.44 |
| Current ratioi | 1.59 | 1.65 | 1.62 | 1.74 | 1.56 | 1.65 | 1.79 | 2.07 |
| Quick ratioi | 1.14 | 1.19 | 1.20 | 1.25 | 0.84 | 1.24 | 1.36 | 1.61 |
| Debt / assetsi | 20.94 | 21.08 | 24.99 | 27.28 | 25.34 | 27.18 | 31.04 | 29.46 |
| LT debt / equityi | 45.93 | 37.00 | 60.83 | 63.51 | 58.49 | 65.53 | 70.63 | 73.80 |
| Interest coveragei | 21.37 | 24.00 | 14.21 | 8.51 | 17.90 | 14.58 | 7.42 | 6.29 |
| Revenue CAGR (3Y) %i | 9.49 | 3.88 | 1.23 | 3.88 | 7.51 | 11.78 | 6.07 | 4.25 |
| Net income CAGR (3Y) %i | 17.28 | 7.83 | 4.35 | -16.76 | 8.16 | 7.72 | -14.30 | -33.55 |
| FCF CAGR (3Y) %i | 25.91 | -0.51 | 5.26 | 6.16 | 1.92 | -7.89 | 1.65 | 29.36 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.00 | 3.50 | 2.21 | 5.05 | 6.46 | 7.19 |
| ROA %i | 2.07 | 1.47 | 0.90 | 2.00 | 2.63 | 2.93 |
| ROIC %i | 3.26 | 2.41 | 1.59 | 3.12 | 4.01 | 4.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.13 | 4.07 | 3.88 | 4.35 | 5.00 | 5.61 |
| FCF / sales %i | 7.14 | 8.58 | 8.89 | 8.44 | 8.75 | 8.66 |
| Current ratioi | 1.97 | 2.02 | 2.05 | 2.07 | 2.13 | 2.13 |
| Quick ratioi | 1.51 | 1.57 | 1.60 | 1.61 | 1.65 | 1.66 |
| Debt / assetsi | 29.21 | 28.31 | 28.01 | 29.46 | 29.83 | 29.17 |
| LT debt / equityi | 68.92 | 68.09 | 67.09 | 73.80 | 73.57 | 71.61 |
| Interest coveragei | 5.96 | 5.49 | 5.24 | 6.29 | 7.46 | 8.30 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Drivetrain & Morse Systems is the largest reported line at 39.88% of revenue, across 5 reported segments.
- No single line clears half of revenue; Turbos & Thermal Technologies is next at 39.53%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Drivetrain & Morse Systems39.88%
Turbos & Thermal Technologies39.53%
PowerDrive Systems18.23%
Battery Energy Systems2.74%
Quote time 2026-10-08 07:37:38 · For reference only, not investment advice and not tailored to your situation.